Abstract |
Between 1986 and 1990, 50 venous access devices have been implanted in 45 children with various types of cancer and in one patient with Langerhans cell histiocytosis. Twenty-five devices were of the so-called "pediatric" type ( Port-A-Cath: 24, Vascuport: 1) and 25 were "adult" ports ( Port-A-Cath: 8, Vascuport: 6, Infuse-A-Port: 6, Theraport: 5). The catheters (in silicone elastomer or polyurethane) were inserted percutaneously or surgically. Cumulative total venous access was 15024 patient-days (mean: 290 days per patient, range 2-900 days). Occlusion of the system, the most frequent complication, was encountered in 5 patients (11%). Rarer complications were catheter-related infection (2 pts), pneumothorax (1 pt), skin necrosis (1 pt), catheter leakage (1 pt) and port-catheter disconnection (1 pt). No serious complication ever occurred in 35 patients (76%). Seven of the 11 complications, including all 3 port occlusions, were encountered with "pediatric" systems. All the adult access devices tested were safe and allowed long-standing access to the central venous system in this series of pediatric cancer patients. With proper placement technique and adequate nursing care, they represent a definite improvement in child cancer therapy.
|
Authors | A De Backer, A Vanhulle, J Otten, P Deconinck |
Journal | European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie
(Eur J Pediatr Surg)
Vol. 3
Issue 2
Pg. 101-6
(Apr 1993)
ISSN: 0939-7248 [Print] United States |
PMID | 8323914
(Publication Type: Comparative Study, Journal Article)
|
Topics |
- Adolescent
- Blood Specimen Collection
(instrumentation)
- Catheterization, Central Venous
(instrumentation)
- Child
- Child, Preschool
- Equipment Design
- Equipment Failure
- Female
- Humans
- Infant
- Infusion Pumps, Implantable
- Leukemia
(therapy)
- Male
- Neoplasms
(therapy)
|